Skip to content

Closure of Mucosal and Submucosal Defects in the Gastrointestinal Tract Using the Novel X-Tack Endoscopic Suturing Device

Closure of Mucosal and Submucosal Defects in the Gastrointestinal Tract Using the Novel X-Tack Endoscopic Suturing Device

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04925271
Enrollment
40
Registered
2021-06-14
Start date
2021-07-01
Completion date
2022-07-30
Last updated
2023-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fistula, Polyp of Colon

Keywords

Endoscopic submucosal dissection, Suturing

Brief summary

After removing large polyps from the gastrointestinal tract, gastroenterologists close the new defect with devices to prevent complications like bleeding or the development of a leak. Commonly, this is done with a device called Overstitch, which allows the gastroenterologist to stitch the defect with an endoscope. A new device called X-tack has been developed to simplify endoscopic stitching. In this study, the new X-tack device will be compared to Overstitch when closing defects in the gastrointestinal tract. The two devices will be compared to see how long it takes to close a defect, as well as if there are any differences in complications like bleeding or infection.

Detailed description

Currently, the community standard is that gastroenterologists who are familiar with Overstitch start using the X-Tack without additional training. However, a hands-on demonstration session with the X-Tack device in a dry lab has been conducted with each endoscopist in the trial prior to the study in order to familiarize them with device before enrollment. Each endoscopist has also participated in a wet lab using an explant (porcine stomach) to simulate in vivo closure of defects using the X-Tack system. The device operates in a similar fashion compared to previous suturing devices, which are used frequently by all endoscopists involved in this study. On this basis, all endoscopists in the study report comfort and familiarity with the X-Tack system, and the break-in period is not anticipated to affect safety or results during the study. The primary study visit will be comprised of the endoscopic procedure at the time of defect closure and a telephone call 48-72 hours later to assess for complications. Patient will be enrolled in the pre-procedure area. If the patient has a pre-procedure visit, they may be notified of their potential for enrollment in the study at that time, though not all patients have a pre-procedure visit in our practice. Patients will be randomized to closure with the X-Tack system versus closure with the Overstitch system prior to their procedure using a centralized computer-generated randomization. Technical success of closure, time of closure, number of sutures required, need for alternative modalities for closure, and any intraprocedural complications (bleeding, perforation) will be recorded. Any patient with possible periprocedural perforation will receive antibiotics at the endoscopist's discretion. At the endoscopist's discretion, the patient may cross over during the procedure to the other group if they believe that their current closure strategy is failing to safely close the defect. Alternate methods of closure (TTS clips, over-the-scope clips) may be used in either group if required by the endoscopist for safe closure of the defect. After the procedure, most patients are observed in the recovery area for 1-2 hours for any signs of complications before they are discharged home.

Interventions

DEVICEX-Tack

The mucosal or submucosal defect is closed with X-Tack.

DEVICEOverstitch

The mucosal or submucosal defect is closed with Overstitch.

Sponsors

Thomas Jefferson University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

Patients undergoing closure of a mucosal or submucosal defect in the gastrointestinal tract will be randomized 1:1 to either closure with X-Tack or closure with Overstitch.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* \> 18 years of age * Undergoing closure of a gastrointestinal luminal defect for which a suturing device would be otherwise indicated

Exclusion criteria

* INR \> 2 * Platelets \< 150 * Ongoing anticoagulation not meeting ASGE Antithrombotic Guidelines (Acosta RD et al, The Management of Antithrombotic Agents for Patients Undergoing GI Endoscopy, Gastrointest Endosc, 2016; 83(1): 3-16) * Hemodynamic instability * Ongoing or anticipated pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Time to ClosureAt time of endoscopyThe time required to close the defect using the device

Secondary

MeasureTime frameDescription
Incomplete ClosureAt time of endoscopyEither crossover to the other study group per endoscopist's discretion, or the need for additional modalities to close the defect such as endoscopic clips

Countries

United States

Participant flow

Participants by arm

ArmCount
X-Tack
The gastrointestinal tract mucosal or submucosal defect is closed using the X-Tack device. X-Tack: The mucosal or submucosal defect is closed with X-Tack.
20
Overstitch
The gastrointestinal tract mucosal or submucosal defect is closed using the Overstitch device. Overstitch: The mucosal or submucosal defect is closed with Overstitch.
20
Total40

Baseline characteristics

CharacteristicOverstitchTotalX-Tack
Age, Customized
Age
62.2 years
STANDARD_DEVIATION 12.2
62 years
STANDARD_DEVIATION 12
61.8 years
STANDARD_DEVIATION 13.5
Race/Ethnicity, Customized
Race/Ethnicity
Asian
2 Participants4 Participants2 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Black
1 Participants5 Participants4 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Hispanic
1 Participants1 Participants0 Participants
Race/Ethnicity, Customized
Race/Ethnicity
White
16 Participants30 Participants14 Participants
Sex: Female, Male
Female
11 Participants21 Participants10 Participants
Sex: Female, Male
Male
9 Participants19 Participants10 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 200 / 20
other
Total, other adverse events
0 / 200 / 20
serious
Total, serious adverse events
2 / 200 / 20

Outcome results

Primary

Time to Closure

The time required to close the defect using the device

Time frame: At time of endoscopy

ArmMeasureValue (MEAN)Dispersion
X-TackTime to Closure23.3 minutesStandard Deviation 13.9
OverstitchTime to Closure18.4 minutesStandard Deviation 16.9
Secondary

Incomplete Closure

Either crossover to the other study group per endoscopist's discretion, or the need for additional modalities to close the defect such as endoscopic clips

Time frame: At time of endoscopy

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
X-TackIncomplete Closure2 Participants
OverstitchIncomplete Closure3 Participants

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026